TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 12.20 thousand shares for the 12-month period ending 2019-12-31, per its 10-K/A filed 2021-04-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2021-04-16
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-12-31 was 0.00 shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-06-30 was 0.00 shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-03-31 was 12.20K shares, a 52.36% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2019 was 12.20K shares, a 67.41% decline from fiscal 2018.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2018 was 37.42K shares, a 540.97% increase from fiscal 2017.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2017 was 5.84K shares, a 36387.50% increase from fiscal 2016.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2016 was 16.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | 0.00 shares derived: sum of 2 quarters · filed 2021-04-16 | 0.00 shares derived: sum of 3 quarters · filed 2021-04-16 | 12.20K shares 10-K/A · filed 2021-04-16 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-14 | 12.20K shares 10-Q · filed 2019-11-14 | 12.20K shares derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 12.20K shares 10-Q · filed 2019-08-14 | 12.20K shares derived: sum of 3 quarters · filed 2020-03-30 | 24.02K shares derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2019-03-31 | 12.20K shares 10-Q · filed 2019-05-15 | 12.20K shares derived: sum of 2 quarters · filed 2020-03-30 | 24.02K shares derived: sum of 3 quarters · filed 2020-03-30 | 24.02K shares derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 11.82K shares derived: sum of 2 quarters · filed 2020-03-30 | 11.82K shares derived: sum of 3 quarters · filed 2020-03-30 | 37.42K shares 10-K · filed 2020-03-30 | ||
| 2018-09-30 | 11.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 11.82K shares derived: sum of 2 quarters · filed 2018-11-14 | 37.42K shares 10-Q · filed 2018-11-14 | -73.27K shares derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 25.60K shares 10-Q · filed 2018-08-14 | -85.09K shares derived: sum of 3 quarters · filed 2019-04-01 | -85.09K shares derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-03-31 | 25.60K shares 10-Q · filed 2018-05-15 | -85.09K shares derived: sum of 2 quarters · filed 2019-04-01 | -85.09K shares derived: sum of 3 quarters · filed 2019-04-01 | -85.03K shares derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2017-12-31 | -110.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -110.69K shares derived: sum of 2 quarters · filed 2019-04-01 | -110.64K shares derived: sum of 3 quarters · filed 2019-04-01 | 5.84K shares 10-K · filed 2019-04-01 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 52.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 116.53K shares 10-Q · filed 2017-11-09 | 116.30K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-06-30 | 52.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 116.53K shares 10-Q · filed 2017-08-09 | 116.30K shares derived: sum of 3 quarters · filed 2018-04-02 | 116.39K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-03-31 | 116.47K shares 10-Q · filed 2017-05-10 | 116.25K shares derived: sum of 2 quarters · filed 2018-04-02 | 116.34K shares derived: sum of 3 quarters · filed 2018-04-02 | 116.41K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2016-12-31 | -224.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -137.00 shares derived: sum of 2 quarters · filed 2018-04-02 | -61.00 shares derived: sum of 3 quarters · filed 2018-04-02 | 16.00 shares 10-K · filed 2018-04-02 | 327.00 shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 87.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 163.00 shares derived: sum of 2 quarters · filed 2016-11-09 | 240.00 shares 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | 76.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 153.00 shares 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | 77.00 shares 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | 174.00 shares 10-K · filed 2017-03-16 | |||||
| 2015-10-31 | 87.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | 174.00 shares 10-Q · filed 2015-12-10 | 258.00 shares derived: sum of 3 quarters · filed 2017-03-16 | 335.00 shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-07-31 | 87.00 shares 10-Q · filed 2015-09-09 | 171.00 shares derived: sum of 2 quarters · filed 2017-03-16 | 248.00 shares derived: sum of 3 quarters · filed 2017-03-16 | 47.74K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-04-30 | 84.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 161.00 shares derived: sum of 2 quarters · filed 2017-03-16 | 47.66K shares derived: sum of 3 quarters · filed 2017-03-16 | 29.96K shares 10-K · filed 2017-03-16 | -29.96K shares 10-K · filed 2015-07-14 | |
| 2015-01-31 | 77.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | 47.57K shares derived: sum of 2 quarters · filed 2015-03-17 | 29.87K shares 10-Q · filed 2015-03-17 | 29.96K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-10-31 | 47.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | 29.80K shares 10-Q · filed 2014-12-15 | 29.88K shares derived: sum of 3 quarters · filed 2017-03-16 | 29.97K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-07-31 | -17.70K shares 10-Q · filed 2014-09-15 | -17.62K shares derived: sum of 2 quarters · filed 2017-03-16 | -17.53K shares derived: sum of 3 quarters · filed 2017-03-16 | 31.15K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-04-30 | 83.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 173.00 shares derived: sum of 2 quarters · filed 2017-03-16 | 48.85K shares derived: sum of 3 quarters · filed 2017-03-16 | 50.23K shares 10-K · filed 2017-03-16 | ||
| 2014-01-31 | 90.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | 48.77K shares derived: sum of 2 quarters · filed 2014-03-17 | 50.15K shares 10-Q · filed 2014-03-17 | -18.86K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-10-31 | 48.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | 50.06K shares 10-Q · filed 2013-12-17 | -18.95K shares derived: sum of 3 quarters · filed 2016-03-14 | 3.54K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-07-31 | 1.38K shares 10-Q · filed 2013-09-17 | -67.63K shares derived: sum of 2 quarters · filed 2016-03-14 | -45.14K shares derived: sum of 3 quarters · filed 2016-03-14 | -7.65K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-04-30 | -69.01K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | -46.53K shares derived: sum of 2 quarters · filed 2016-03-14 | -9.04K shares derived: sum of 3 quarters · filed 2016-03-14 | 4.46K shares 10-KT · filed 2016-03-14 | ||
| 2013-01-31 | 22.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | 59.97K shares derived: sum of 2 quarters · filed 2013-03-18 | 73.48K shares 10-Q · filed 2013-03-18 | |||
| 2012-10-31 | 37.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | 50.99K shares 10-Q · filed 2012-12-14 | ||||
| 2012-07-31 | 13.50K shares 10-Q · filed 2012-09-19 | |||||
| 2012-04-30 | 1.60K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |